Clinical Trials Directory

Trials / Conditions / DiGeorge Syndrome

DiGeorge Syndrome

16 registered clinical trials studyying DiGeorge Syndrome — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingHematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmun
NCT07284641
Paul SzabolcsPhase 2
RecruitingExamining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
NCT00556530
Albert Einstein College of Medicine—
CompletedExpanded Noninvasive Genomic Medical Assessment: The Enigma Study
NCT02787486
Progenity, Inc.—
CompletedSNP-based Microdeletion and Aneuploidy RegisTry (SMART)
NCT02381457
Natera, Inc.—
UnknownWhole Blood Specimen Collection From Pregnant Subjects
NCT02430584
Progenity, Inc.—
Active Not RecruitingImmune Disorder HSCT Protocol
NCT01821781
Washington University School of MedicinePhase 2
CompletedThymus Transplantation Safety-Efficacy
NCT01220531
Sumitomo Pharma Switzerland GmbHN/A
TerminatedEffects of PTH Replacement on Bone in Hypoparathyroidism
NCT00395538
National Institute of Dental and Craniofacial Research (NIDCR)Phase 3
CompletedVelocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
NCT00105274
National Institute of Mental Health (NIMH)—
CompletedParathyroid and Thymus Transplantation in DiGeorge #931
NCT00566488
Sumitomo Pharma Switzerland GmbHPhase 1
CompletedThymus Transplantation Dose in DiGeorge #932
NCT00576836
Sumitomo Pharma Switzerland GmbHPhase 2
CompletedThymus Transplantation With Immunosuppression
NCT00579709
Sumitomo Pharma Switzerland GmbHPhase 1
CompletedStudy of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
NCT00004351
National Institute of Neurological Disorders and Stroke (NINDS)—
TerminatedInfection in DiGeorge Following CHD Surgery
NCT00278005
Children's Healthcare of Atlanta—
UnknownImmunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
NCT00005102
National Center for Research Resources (NCRR)—
CompletedThymus Transplantation in DiGeorge Syndrome #668
NCT00576407
Sumitomo Pharma Switzerland GmbHPhase 2